MTM center supported by pharmacy techs
WASHINGTON — A groundbreaking call center at the University of Arizona College of Pharmacy that delivers medication therapy management services to patients with chronic illnesses utilizes pharmacy technicians certified by the Pharmacy Technician Certification Board.
PTCB said that while pharmacists work directly with patients, their providers, and fellow community pharmacists — to ensure that patients receive optimal treatment while reducing the risk of adverse events and drug interactions — at the school’s Medication Management Center, pharmacy technicians also are involved with supporting the MTM delivery process by scheduling patient appointments, gathering patient information, providing quality assurance reviews of patient and provider communications, conducting customer satisfaction surveys, and reporting outcomes.
The center has delivered MTM services to more than 400,000 Medicare beneficiaries across the country since 2006.
"Pharmacy technicians are integral members of our pharmacy team," Medication Management Center director Kevin Boesen said. "By expanding pharmacy technicians’ roles within the Center, pharmacists are able to spend more time working directly with patients and, as a result, we have witnessed significant improvements in medication compliance and overall patient health outcomes."
PTCB executive director and CEO Melissa Murer Corrigan added, "The model developed by the University of Arizona Medication Management Center is a great example of how integrated pharmacy teams positively benefit patients,. Certified pharmacy technicians continue to take on innovative roles that allow pharmacists to increase their involvement in direct patient care, which in turn, may reduce the overall cost burden on patients and the health care system."
For more information on the University of Arizona College of Pharmacy’s Medication Management Center, click here.
Take Care Health Systems opens on-site medical center, pharmacy at Sanofi U.S. HQ
BRIDGEWATER, N.J. — Take Care Health Systems, which is owned by Walgreens, and Sanofi U.S. have announced the opening of a full-service medical center and on-site pharmacy at Sanofi’s U.S. headquarters in Bridgewater, N.J.
The Sanofi health center and pharmacy is operated by Take Care Health Systems and serves 2,600 employees in the Bridgewater area. Services include primary care, urgent care, laboratory services, preventive care, wellness, health screenings, patient education and disease management. In addition, the on-site pharmacy provides medication counseling, prescription transfers, automatic refills and OTC items.
The clinic and pharmacy will help employees achieve and maintain improved health outcomes by allowing them to manage their healthcare needs during the workday, and Sanofi will evaluate these outcomes to guide future decisions on employee wellness offerings.
“As a global healthcare company that is dedicated to solving health challenges, it is essential for us to know that we are doing everything we can to help our own employees and their dependents stay well,” stated Sanofi’s Judy O’Hagan, VP U.S. human resources. “By providing access to the broad range of healthcare services that will be made available through this health center and pharmacy combination, we will offer a cost-conscious, convenient approach to health care for our employees.”
In addition to the on-site clinic and pharmacy, the company offers a variety of health-and-wellness services at sites across the United States. Sanofi recently distributed vouchers to all U.S. employees and dependents for a flu shot, redeemable at any Walgreens throughout the country.
“Sanofi is a true innovator that continues to demonstrate a commitment to their employees by offering a robust array of health services at the worksite,” stated Peter Hotz, Walgreens group VP. “This is an example of a leading company working with Walgreens to deliver and develop innovative health services and worksite offerings that can drive improved patient outcomes, overall savings and happier and more productive employees."
Recent research has demonstrated that the face-to-face counseling and convenient access provided by the combination of an on-site pharmacy and full-service health center can drive a nearly 10% increase in medication adherence. Nonadherence is a significant health issue; up to 11% of hospital admissions can be attributed to nonadherence of medication therapy, and it currently costs an estimated $100 billion a year to the national healthcare system.
FDA approves first-ever drug for rare blood disorder
SILVER SPRING, Md. — The Food and Drug Administration has approved a treatment made by Alexion Pharmaceuticals for a rare blood disorder that affects children.
The FDA announced the approval of Soliris (eculizumab) for atypical hemolytic uremic syndrome, a rare and chronic disease that can lead to kidney failure, stroke and death. According to the FDA, aHUS accounts for 5% to 10% of all cases of hemolytic uremic syndrome.
"This is the first approval of a drug for treating this life-threatening disease, and the first approval for use of Soliris in children," FDA Office of Hematology and Oncology Products Richard Pazdur said. "This approval underscores how an increased understanding of the biology of the disease and how a drug interacts with that process can expedite drug development."